Table 2 |
|||
|
Treatment coverage in probable malaria cases, Makamba province, Burundi, 2004 (n = 165) |
|||
| Treatment |
N |
[%]* |
95%CI |
|
|
|||
| Strict definition of AS+AQ coverage† |
|||
| AS+AQ |
13 |
9.4 |
3.8–15.0 |
| Quinine |
10 |
5.0 |
1.7–8.4 |
| Other treatments |
75 |
45.6 |
36.5–54.6 |
| Traditional treatment |
6 |
3.4 |
0.5–6.3 |
| No treatment |
61 |
36.5 |
27.7–45.3 |
| Lenient definition of AS+AQ coverage‡ |
|||
| AS+AQ |
20 |
14.1 |
7.6–20.3 |
| Quinine |
10 |
5.0 |
1.7–8.4 |
| Other treatments |
68 |
41.0 |
32.1–50.0 |
| Traditional treatment |
6 |
3.4 |
0.5–6.3 |
| No treatment |
61 |
36.5 |
27.7–45.3 |
| Treatment coverage with any antimalarial |
|||
| AS+AQ/Quinine |
30 |
19.1 |
12.1–26.0 |
| Other treatments |
68 |
41.0 |
32.1–50.0 |
| Traditional treatment |
6 |
3.4 |
0.5–6.3 |
| No treatment |
61 |
36.5 |
27.7–45.3 |
| Total |
165 |
100.0 |
|
|
|
|||
|
* Weighted percentage † Received AS+AQ in a public health centre within 48 hours after onset of fever ‡ Received AS+AQ |
|||
|
Gerstl et al. Malaria Journal 2007 6:94 doi:10.1186/1475-2875-6-94 |
|||